![Gail Farfel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gail Farfel
Directeur/Membre du Conseil chez
PrintedArt
Profil
Gail M.
Farfel currently works at Dravet Syndrome Foundation, Inc., as Director, PrintedArt, as Director, FAAH Pharma, Inc., as Director from 2014, and American Society For Experimental Neurotherapeutics, as Director.
Dr. Farfel also formerly worked at ProMIS Neurosciences, Inc., as President, Chief Executive Officer & Director in 2023, Pfizer Inc., as Senior Associate Director, DURECT Corp., as Independent Director from 2019 to 2025, Zogenix International Ltd., as Director from 2015 to 2022, AVROBIO, Inc., as Director from 2020 to 2024, Marinus Pharmaceuticals, Inc., as Chief Clinical & Regulatory Officer from 2012 to 2015, Novartis Pharmaceuticals Corp., as VP-Therapeutic Area & Head-Neuroscience from 2006 to 2008, Pfizer Pharmaceuticals, Inc., as Global Team Lead from 1994 to 2006, G Meredith Consulting LLC, as President in 2012, and Zogenix, Inc., as Chief Development Officer & Executive VP from 2015 to 2022.
Dr. Farfel received her undergraduate degree from the University of Virginia and doctorate degree from The University of Chicago.
Postes actifs de Gail Farfel
| Sociétés | Poste | Début |
|---|---|---|
PrintedArt
 PrintedArt Other Consumer ServicesConsumer Services Provides photography and printing service | Directeur/Membre du Conseil | - |
American Society For Experimental Neurotherapeutics
 American Society For Experimental Neurotherapeutics American Society For Experimental Neurotherapeutics is a company. 'The company is based in Haddonfield. | Directeur/Membre du Conseil | - |
FAAH Pharma, Inc.
 FAAH Pharma, Inc. BiotechnologyHealth Technology Operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia | Directeur/Membre du Conseil | 07/08/2014 |
Dravet Syndrome Foundation, Inc.
 Dravet Syndrome Foundation, Inc. Dravet Syndrome Foundation, Inc. is an American company. 'The company is based in Cherry Hill. | Directeur/Membre du Conseil | - |
Anciens postes connus de Gail Farfel
| Sociétés | Poste | Fin |
|---|---|---|
| DURECT | Directeur/Membre du Conseil | 11/09/2025 |
| TECTONIC THERAPEUTIC, INC. | Directeur/Membre du Conseil | 20/05/2024 |
| PROMIS NEUROSCIENCES, INC. | Directeur Général | 30/12/2023 |
| ZOGENIX, INC. | Corporate Officer/Principal | 01/09/2022 |
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Treats a chronic form of epilepsy | Directeur/Membre du Conseil | 01/03/2022 |
Formation de Gail Farfel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zogenix International Ltd.
Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Treats a chronic form of epilepsy | Health Technology |
PrintedArt
PrintedArt Other Consumer ServicesConsumer Services Provides photography and printing service | Consumer Services |
FAAH Pharma, Inc.
FAAH Pharma, Inc. BiotechnologyHealth Technology Operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia | Health Technology |
G Meredith Consulting LLC | |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
American Society For Experimental Neurotherapeutics
American Society For Experimental Neurotherapeutics American Society For Experimental Neurotherapeutics is a company. 'The company is based in Haddonfield. | |
Dravet Syndrome Foundation, Inc.
Dravet Syndrome Foundation, Inc. Dravet Syndrome Foundation, Inc. is an American company. 'The company is based in Cherry Hill. |
